Head-to-head · Value Score
CoreAge Rx vs Shape Vantage
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Shape Vantage a 44. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$149/mo
Save ~89% vs brand-nameShape Vantage
#390 · Grade C · Watch List
Est. first month
From $599/mo (compounded)
Save ~56% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 44 — an est. $149/mo first month, with no teaser step-up baked in. Shape Vantage isn't out of it: Shoppers who want transparency listing only — LOW confidence, not recommended.
CoreAge Rx is also our overall #1 pick across the whole deals board — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Shape Vantage |
|---|---|---|
| Value Score | 93 (A+) | 44 (C) |
| Est. first month | $149/mo | From $599/mo (compounded) |
| Save vs brand-name | ~89% | ~56% |
| Semaglutide | $149/mo | Not disclosed |
| Tirzepatide | $349/mo | From $599/mo (compounded) |
| Both molecules | Yes | No |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Shape Vantage
Shape Vantage is a tirzepatide reseller with a hybrid grey-market profile that does not match the typical compounded-telehealth model.
Why it's a deal
- $599 product price shown publicly, not gated behind intake
- Terms of Service exists and discloses the legal relationship
- Positions itself as 'Premium Weight Loss Treatment'
The fine print
- Homepage uses a dietary-supplement-style disclaimer, not language seen on legitimate prescription products
- Links straight to a Stripe checkout with no medical intake, consultation, or prescription gate
- Terms reserve the option to ship without prescription or provider review where not legally required
- No LegitScript, NABP, state-pharmacy, or PCAB accreditation visible
- Legal entity and state of incorporation not disclosed (only California governing law)
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives board, and the same list for the other side is on alternatives to Shape Vantage.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.